UPDATE 2-U.S. FDA warns CR Bard about Puerto Rico plant

(Adds company comment)

WASHINGTON, Oct 14 (Reuters) - U.S. regulators have told medical device maker C.R. Bard Inc (BCR.N) to correct manufacturing problems uncovered during an inspection of a plant in Puerto Rico, a letter released on Tuesday said.

Food and Drug Administration inspectors who visited the plant from November 2007 through February 2008 found practices that were "not in conformity" with federal manufacturing standards, a July 22 letter from the FDA said.

Devices made at the plant in Humacao, Puerto Rico, include the Kugel Hernia Patch and the Vacora Biopsy Probe, the letter said.

The warning letter was posted on the FDA web site on Tuesday here

C.R. Bard spokeswoman Holly Glass said the company had disclosed the letter July 28 in a quarterly filing with the Securities and Exchange Commission. In that filing, the company said it "intends to fully implement corrective actions to address the concerns identified."

C.R. Bard shares fell $1.46, or 1.8 percent, to $81.93 in morning trading on the New York Stock Exchange. (Reporting by Lisa Richwine; Editing by Gerald E. McCormick and Maureen Bavdek)